about
Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate.Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort.The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patientsAssociation of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDSLong-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment.Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients.Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens.Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.
P50
Q33269695-614818B4-CBB5-42ED-AF7F-B5CC51225A31Q33794298-11A1780C-FA75-4367-8DFC-54310CE217D7Q34253604-FCB7DB2A-4EE3-4DCC-8E83-004DCE1E26A2Q34626108-A74CA35F-490E-4E42-8414-AD7803079E24Q36682506-A44989B4-0ACF-4072-B758-FD1E327C1AC6Q36708715-37AF6A8A-53D5-418D-B25A-AC61DC18FE52Q37154865-9B5B6538-9862-4EB6-95AC-1000BB61BAA7Q40892448-788ED78C-C956-47D8-BFB8-60FE02BA31D4Q42244747-8970848B-E4F9-4DDA-96AA-1E981487E0E1Q42278334-939D9200-C495-42E9-A132-C5F400F9DD67Q43649205-9E10720D-83AC-4CB9-B1F0-5C95568517A9Q46558862-499B50F8-C4DB-4660-A10A-DCB3671F589D
P50
name
Heribert Knechten
@ast
Heribert Knechten
@en
Heribert Knechten
@es
Heribert Knechten
@fr
Heribert Knechten
@nl
type
label
Heribert Knechten
@ast
Heribert Knechten
@en
Heribert Knechten
@es
Heribert Knechten
@fr
Heribert Knechten
@nl
prefLabel
Heribert Knechten
@ast
Heribert Knechten
@en
Heribert Knechten
@es
Heribert Knechten
@fr
Heribert Knechten
@nl